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Introduction
Adult skeletal muscle homeostasis as well as myofiber repair are maintained by a small subset of muscle stem/progenitor cells called Myosatellites or Satellite Cells (SCs).
SCs reside between the sarcolemma and the basal membrane of skeletal muscle fibers and are able to give rise to additional SCs or differentiate into mature skeletal muscle cells to form new fibers [1, 2] . The members of the MyoD family (Myod, Myf5, Myogenin and Mrf4) are basic helix-loop-helix (bHLH) transcription factors that are critical molecular mediators of skeletal muscle differentiation [3] . Myod and Myf5 are considered promote the early stages of differentiation regulating skeletal muscle cell commitment, proliferation and cell cycle withdrawal of SCs [4] , whereas Myogenin and Mrf4 mediate the processes of late muscle cell differentiation, promoting the formation and the final maturation of myotubes [5, 6] .
High mobility group (HMG) proteins are non-histone chromatin associated proteins that indirectly modulate the transcription of their targets by altering higher order chromatin structure. HMGA1 is expressed in embryonic and undifferentiated cells, but is largely absent in adult organs [7] . HMGA1 down-regulation in C 2 C 12 cell line is required to initiate the skeletal muscle differentiation program allowing the expression of the MyoD family myogenic factors [8] . However, little is known about the regulatory mechanisms that influence HMGA1 expression during myogenic differentiation.
The ε isoform of the PKC family (PKC) is a serine-threonine kinase that is expressed in a wide variety of tissues including the hematopoietic system, intestine, brain, skin, liver, adipose tissue, kidney as well as cardiac and skeletal muscle. In many of these, PKC regulates tissue homeostasis by regulating cell death and differentiation [9] [10] [11] [12] [13] [14] . It is known that the  isoform of the PKC family promotes the fusion of myoblasts and regulates 5 the expression of caveolin-3 and β1D integrin [15] . Of note, it has also been demonstrated that PKC expression increases during insulin-induced myogenic differentiation of the C 2 C 12 cells [16] .
In this study we investigated the functional role of PKC in skeletal muscle cell differentiation as well as a potential role of PKC as an upstream suppressor of Hmga1. We found that inhibition of PKC prevents myogenic differentiation of C 2 C 12 and primary SCs, whereas its overexpression accelerates cell differentiation. In vivo, PKC inhibition results in impaired muscle regeneration and reduced expression of Myogenin and Mrf4.
Mechanistically, we show that PKC down-regulates Hmga1 expression, which consequently leads to the increase expression of myogenic differentiation genes. Finally, we demonstrate PKC inhibition obstructs the process of injury-induced muscle regeneration in vivo.
Mice
The experimental procedures were conducted according to the "Guide for the Care and Use of Laboratory Animals" (Directive 2010/63/EU of the European Parliament).
All the procedures described in this study were also approved by the Local Animal Research Ethics Committee of Ferrara (C.E.A.S.A) and Parma.
Cardiotoxin injury and immunohistochemistry
Acute injury was induced by intramuscular injection of Cardiotoxin (10 μM) in the tibialis muscle of CD1 adult mice [17] . In the case of PKC -active peptides treatment, V1-2 or ψRACK (100 nM) were injected together with cardiotoxin. To study the regenerative process, mice were euthanized for histological analysis 3 and 7 days after injury. Muscle samples were fixed with 4% paraformaldehyde and embedded in paraffin. Sections (4 µm) were blocked with goat serum and incubated with primary anti PKC antibody (Novus Biological NBP1-30126). Detection was performed using Vectastain elite ABC kit (Vector Laboratories) and nuclei were counterstained with haematoxylin [18] .
Cell cultures
Mouse myoblast C 2 C 12 cell line and primary SC were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with heat-inactivated 10% fetal bovine serum (FBS), 2mM glutamine and 1% antibiotics (Growth Medium, GM). Cells were maintained in a humidified 5% CO 2 atmosphere at 37°C. When the cell cultures reached 80% confluence, GM was substituted with DMEM supplemented with 2% horse serum (Differentiation Medium, DM) to induce myogenic differentiation. Each experiment was performed in triplicate.
Satellite cells isolation
SCs were isolated from hindlimb muscles of 2 days old CD1 mice. Briefly, muscles were incubated with collagenase/dispase solution (Roche, Basel, Switzerland) 4 times for 15 minutes at 37°C in agitation. Cell suspension was filtered with 40 µm nylon cell strainer and processed with Feeder Removal Microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). This immunomagnetic separation kit allows depletion of mouse fibroblasts from muscle digestion and ensures higher levels of SC purity than the "pre-plating SC isolation" method [17] .The SC obtained were seeded at a density of 1.25 x 10 5 /cm 2 in collagen-coated culture dishes and grown in fibroblast-conditioned GM medium (fcGM). fcGM was obtained diluting (1:1 ratio) the filtered supernatant of primary cultures of mouse fibroblasts with fresh GM medium.
RNA extraction and quantitative RT-PCR
Total RNA was extracted using the RNeasy mini kit (Qiagen) according to the manufacturer's instructions. 1 μg of total RNA was reverse transcribed using ImProm-II™ Reverse Transcription System (Promega, Fitchburg, WI) in a final volume of 20 μl.
Quantitative real-time PCR assay of mouse differentiation myogenic markers was performed using Syber Green method. Mouse beta-glucoronidase (Gusb), known to be a good internal control to study mRNA expression in muscular derived cell lines [19] was used to normalize all results. The cycling conditions were: 95°C for 20s followed by 40 cycles of 95°C for 3s and 60°C
for 30s. Real-Time RT-PCR products were confirmed by the analysis of melting curves.
Immunofluorescence
Immunofluorescence was performed as previously described [20] . Briefly, cells were grown in 48 wells dishes containing a cover slide. At the indicated time points, cells were washed in PBS and fixed with 4% paraformaldehyde in PBS for 10 minutes at room temperature and stored in PBS at 4°C. Samples were permeabilized 3 times with 1% BSA, 0.2% Triton X-100 in PBS for 5 minutes at room temperature. Then, cells were incubated in 10% goat serum in PBS for 1 hour at room temperature to saturate non-specific binding (CEAVSLKPT) and ψRACK (CHDAPIGYD) peptides, conjugated to TAT [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] (CYGRKKRRQRRR) by a cysteine disulfide bound [22] . Briefly, V1-2 is a specific PKC inhibitor designed from the C2 region of PKC protein that acts as a binding competitor between PKC and its anchoring protein RACK. Instead, ψRACK is a PKC allosteric activator derived from the C2 region sequence, implicated in auto inhibitory intramolecular interactions. Peptides are high specific for PKC and they don't interact with other PKC isozymes [23] . Peptides regulate both the enzymatic function and the localization of PKCε through the subcellular compartments. 
Statistical analysis
Data sets were examined by analysis of variance (ANOVA) for comparisons between multiple groups and Dunnett's test for comparing a control group to all other groups (when necessary). A P value of less than 0.05 was considered statistically significant.
PKC expression, activation and localization during C 2 C 12 and primary satellite cell differentiation.
To evaluate PKC expression during myotube formation in vitro and ex vivo, C 2 C 12
and SC cells, respectively, were cultured in low serum medium for one week. Quantitative real time PCR analyses at several time points during the differentiation process confirmed that the expression of the early myogenic differentiation markers (Myod and Myf5), progressively decreased during the differentiation of C 2 C 12 and primary SCs. As previously described [24] , the transcription factors of the middle and late phases of skeletal muscle differentiation, Myogenin and Mrf4 accumulated during myofibers formation ( Figure S1 A-B ). Both Pkc mRNA and PKC protein levels progressively increased as proliferating myoblasts transitioned into myotube formation (Figure 1 A-D) .
Immunofluorescence microscopy was then applied to evaluate the subcellular localization of PKC protein during the differentiation of C 2 C 12 cell cultures. In undifferentiated C 2 C 12 cells, PKC levels were low with prevalent peri-nuclear staining ( Figure 1E ). During the first 24 hours of skeletal muscle differentiation, PKC is preferentially localized inside the nucleus (arrow heads, middle panels of Figure 1E ). PKC then increases in both in the nucleus and cytoplasm at 72 hours ( Figure 1E ). The expression of the late muscle cell differentiation marker myosin was not detected in undifferentiated 
In vivo induction of Pkc during muscle regeneration
To extend these initial observations, the impact of modulating Pkc expression skeletal muscle repair and regeneration in vivo was assessed. To induce muscle injury and stimulate repair mechanisms, Cardiotoxin (CTX) was injected into mouse tibialis muscles.
Western blot analyses of bulk muscle tissue revealed that PKC sharply increases at day 3 post-CTX injection and continues to increase for at least 7 days following injury ( Figure 5A and 5B). Histo-pathological analysis showed that the up-regulation of PKC expression is most prominent in the fibers located at the site of injury, including the new regenerating fibers (centrally-nucleated fibers) ( Figure 5C ). Mouse tibialis muscles were then injected with CTX in combination with the PKC inhibitor peptide (V1-2), the PKC activator peptide (ψRACK) or control. Administration of V1-2 inhibitor significantly inhibits CTXinduced PKC phosphorylation ( Figure 5D ) and leads to a significant decrease in the levels In the nucleus, PKC is able to mediate the phosphorylation of many targets and alter their activation, subcellular localization or degradation [26, 27] . We have observed that
Hmga1 is a possible target of nuclear PKC in muscle cell differentiation. HMGA proteins are non-histone architectural elements of chromatin that dynamically modulate DNA-linked processes. These proteins are expressed in embryonic stem cells and in proliferating cells but are not detectable in fully differentiated cells [28] . Li et al. demonstrated that Hmga2 is important for myoblast proliferation and early myogenesis [29] . Also the Hmga1 isoform is known to be involved in muscle differentiation. Notably, Brocher et al. [8] have shown that Hmga1 down-regulation during the early phases of myogenesis is important for inducing the expression of myogenic markers, MyoD and Myogenin. Less is known about the signaling pathway that is involved in Hmga1 regulation during myogenesis. Here, for the first time,
we show that PKC alters Hmga1 expression during in vitro and ex vivo skeletal muscle differentiation. Specifically, we have found that siRNA-mediated inhibition of Hmga1 leads to increased expression of Myogenin and Mrf4 mRNA. We have also observed that the levels of nuclear PKC expression increase in the nucleus upon differentiation and that inhibition of PKC diminishes Myogenin and Mrf4 expression as well as myotube formation. Of note, the inhibition of muscle cell differentiation generated by shRNA Pkc silencing could be completely abrogated by the simultaneous inhibition of Hmga1 expression. As skeletal muscle cell differentiation needs Hmga1 shut down to progress, we suggest that the nuclear translocation of activated PKC is critical for Hmga1 inhibition and SC differentiation.
Our data together with Gogoi et al. observations [30] demonstrate that HMGA1, phosphorylated by PKCε, may reside longer in the heterochromatin preferentially interacting with positively charged histones.
Since PKC promotes myogenic differentiation in vitro and ex vivo, which is a crucial phase of skeletal muscle regeneration, we studied the involvement of this kinase in a model of CTX -induced muscle repair in mice. We found that PKC is up-regulated 7 days after injury, preferentially localizing at regenerating centrally-nucleated fibers. To pursue a better understanding of the PKC involvement in muscle regeneration, we injected (intramuscular) CTX-treated animals with a specific PKC inhibitor peptide (V1-2) to block PKC activation and translocation. The consistent decrease of both Myogenin and Myod expression upon PKC inhibition supports that PKC contributes to the muscle regeneration process in vivo. The PKC activator peptide, ψRACK, did not enhance PKC phosphorylation or the expression of either Myod or Myogenin induced by CTX. We infer that this observation is likely due to PKC activation reaching a plateau level in the injured muscle.
Overall, this study provides the first evidence for a role of the PKC-HMGA1 axis in skeletal muscle differentiation and regeneration.
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